ARCHIVES

NIH director; Targets Increases Favor Established Researchers

This article is from The Cancer Letter archive.

Vol. 23 No. 18 | May 9, 1997

Download PDF Visit The Full Archive

Related Articles

NMP22 Assay More Effective Than Conventional Lab Test

January 27, 2006

Cancer Clinical Trials Approved By NCI Last Month Are Listed

November 29, 2002

Genetic Risk Factor Implicated In Prostate Cancer In Blacks

August 25, 2006

FDA Expands Nexavar Indication To Include Thyroid Cancer

December 27, 2013

IOM Report Urges DOD, VA, Congress To End Tobacco Use In Military.

July 10, 2009

AACI Statement On Cancer Centers Presented to Reform Task Force

April 9, 1993